Table 2.
Potential Barriers to Males From Appalachia Receiving HPV Vaccine.
Health care providers (n = 30) | Community leaders (n = 26) | Parents (n = 28) | Mena (n = 18) | |
---|---|---|---|---|
HPV vaccine safety and side effects | ||||
May cause short-term side effects | + | + | + | + |
May cause long-term side effects | + | + | + | − |
May lead to sexual promiscuity | +/− | +/− | +/− | |
Access to care and vaccination logistics | ||||
Access to quality health care | + | + | + | |
Time and transportation difficulties | + | + | ||
Lack of resources, cost, and insurance coverage | + | + | + | + |
Gender and cultural issues | ||||
HPV vaccine viewed as a female vaccine | + | + | + | + |
HPV vaccination may be viewed as emasculating or embarrassing by males | + | + | + | + |
Sex and STIs are not topics for discussion | + | + | + | +/− |
Note. (+) = Mentioned as a potential barrier; (−) = Mentioned as not being a potential barrier; (+/−) = Mixed feedback regarding potential barrier; Blank = not mentioned. HPV = human papillomavirus; STI = sexually transmitted infection.
Included young adult men ages 18 to 26 years.